Navigation Links
GeneCell International, Miami’s Preferred Cord Blood Laboratory, is Pleased to Announce That July is National Cord Blood Awareness Month
Date:8/1/2013

Miami, Florida (PRWEB) August 01, 2013

This year, GeneCell’s management team vowed to educate, encourage and raise awareness regarding the benefits of cord blood stem cell banking. Storing a newborn’s umbilical cord blood is a simple process and GeneCell is dedicated to be a partner in that process. GeneCell International’s pricing is reasonable, with considerable discounts and payment plans, it ensures that all expecting families will be able to afford it. There are no last-minute registration fees or medical courier fees.

According to the National Heart, Lung, and Blood Institute (NHLBI), National Cord Blood Awareness Month is a program that is promoted and its goal is to increase awareness in the banking of cord blood. The organization has supported research and safety with cord blood transplants. They encourage individuals to learn more about the treatments to advance the scientific knowledge in the field.

"Stem cells from bone marrow and umbilical cord blood have been used extensively in the clinical arena for more than 20 years to treat a variety of diseases, in fact today, approximately 80 different diseases can be treated with umbilical cord blood," said GeneCell's Director of Operations, Jose Cirino. "The clinical applications of umbilical cord blood have been growing by leaps and bounds considering 20 years ago it was thought that cord blood can be used to treat only a handful of different diseases. The other sources of these cells have recently been discovered and are being tested in a multitude of clinical trials including Type I Diabetes, Parkinson's disease, ALS, MS, heart attack, stroke as well as cosmetic applications."

GeneCell International specializes in the collection, transport, processing and cryogenic storage of adult stem cells from various sources including umbilical cord blood, dental pulp, and adipose tissue (fat) that can later be used to treat a variety of diseases. The laboratory is also involved in scientific research and development with a range of stem cells from various adult tissues. The facility is governed and inspected by the FDA as well several other regulating bodies to ensure the safety of these cellular therapies.

GeneCell International, LLC is a trusted provider in the collection, processing and storage of adult stem cells from various sources which have the potential to treat a variety of diseases and disorders. Headquartered in Miami, Florida and with local offices in Central Florida and international offices in Colombia, Costa Rica, Dominican Republic, Honduras, India, Peru, Puerto Rico, and Venezuela, GeneCell operates state-of-the-art laboratories and storage facilities for the cord blood and dental pulp of thousands of clients. For more information and to learn more about cord blood banking, cord tissue, dental pulp, adipose tissue or other GeneCell services, please visit our website at http://www.GeneCell.com.

Read the full story at http://www.prweb.com/releases/2013/8/prweb10986462.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. GeneCell International’s Director of Operations, Jose Cirino, Organizes A Series of Educational Seminars with South Florida's Leading Obstetricians and Gynecologist
2. Lisa Lorraine Reyes Muñoz, GeneCell International’s Physician Relation's Manager Launches Educational Meetings for General Public on Umbilical Cord Blood Stem Cells
3. GeneCell International Gives Back to the Community by Participating in Local Elementary School’s Career Day
4. Drogueria Americana, a Honduran Affiliate of GeneCell International, Presents to a Panel of More Than 100 Leading Dentist on Dental Pulp Stem Cells
5. Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013
6. VWR International, LLC Acquires Sovereign Group
7. Despite Lucentiss Recent Expanded Label for Diabetic Macular Edema, Avastin Remains the Preferred Intravitreal Therapy for Diabetic Macular Edema in the United States
8. University of Colorado Cancer Center Study Shows the Preferred Feeding Method is not the Medically Best in Malnourished Pediatric Cancer Patients
9. Ekahau - A Preferred Provider of Real-Time Location Solutions - Is Awarded an Agreement with the Premier Healthcare Alliance
10. BioMed Realty Trust Declares Second Quarter 2012 Common Stock And Preferred Stock Dividends
11. Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology:
(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
Breaking Biology News(10 mins):